Multiple Myeloma
Showing NaN - NaN of 40
Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
-
Orange, California
- +270 more
Apr 11, 2023
Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)
Recruiting
- Multiple Myeloma
-
Benowa, Queensland, Australia
- +132 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- JNJ-68284528
- +4 more
-
Birmingham, Alabama
- +87 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)
Active, not recruiting
- Multiple Myeloma
- Dara SC
- Dara IV
-
Boston, Massachusetts
- +145 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)
Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib 20 mg/m^2
- +4 more
-
Gilbert, Arizona
- +107 more
Dec 20, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +150 more
Dec 9, 2022
Carfilzomib Among Multiple Myeloma Patients in Europe
Completed
- Multiple Myeloma
-
Braunau, Austria
- +114 more
Dec 8, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
-
Woolloongabba, Queensland, Australia
- +117 more
Aug 3, 2022
Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))
Recruiting
- Multiple Myeloma
- +13 more
- RITA (App)
-
Milano, ItalyASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Tucson, Arizona
- +131 more
Jul 1, 2022
Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))
Completed
- Lymphoma
- Multiple Myeloma
- Lenalidomide
- +4 more
-
Muscle Shoals, Alabama
- +215 more
May 5, 2022
Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- New Diagnosis Tumor
- Carfilzomib
- +2 more
-
Alessandria, Italy
- +41 more
Mar 24, 2022
Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Deletion 17P Syndrome
- Daratumumab
- +2 more
-
Ancona, Italy
- +14 more
Mar 24, 2022
Multiple Myeloma Trial in Italy, Netherlands (CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE)
Active, not recruiting
- Multiple Myeloma
- CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE
-
Rionero In Vulture, PZ, Italy
- +12 more
Mar 24, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- Pom/dex (Pomalidomide plus low dose Dexamethasone)
-
Tucson, Arizona
- +163 more
Feb 25, 2022
Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)
Completed
- Multiple Myeloma
-
Graz, Austria
- +111 more
Dec 10, 2021
Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)
Completed
- Multiple Myeloma
- HLA Matched allogeneic transplant
-
Wien, Austria
- +23 more
Oct 5, 2021
Multiple Myeloma Trial in Worldwide (Pomalidomide and Dexamethasone)
Completed
- Multiple Myeloma
- Pomalidomide and Dexamethasone
-
Linz, Austria
- +21 more
Aug 25, 2021
Multiple Myeloma Trial in Italy (Observation)
Recruiting
- Multiple Myeloma
- Observation
-
Ancona, Italy
- +9 more
Aug 6, 2021
Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Durvalumab
- +2 more
-
Little Rock, Arkansas
- +34 more
Aug 4, 2021